AVXL — Anavex Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Anavex Life Sciences, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	29.2	152	149	151	132
Net Total Receivables	4.85	9.14	3.19	2.71	2.45
Prepaid Expenses
Total Other Current Assets
Total Current Assets	34.5	162	153	154	136
Total Assets	34.5	162	153	154	136
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	7.31	10.8	10.2	12.5	15.3
Total Long Term Debt
Total Debt
Total Liabilities	7.31	10.8	10.2	12.5	15.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	27.2	151	142	142	120
Total Liabilities & Shareholders' Equity	34.5	162	153	154	136
Total Common Shares Outstanding